Medpace Holdings, Inc. (MEDP) Return on equity 2016–2025
Medpace Holdings, Inc. (MEDP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
98.3%FY2025 · since FY2016: 2.2% → 98.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.3% | +49.3 pp |
| FY2024 | 49.0% | -1.6 pp |
| FY2023 | 50.6% | -12.9 pp |
| FY2022 | 63.5% | +44.4 pp |
| FY2021 | 19.1% | +1.0 pp |
| FY2020 | 18.0% | +4.2 pp |
| FY2019 | 13.8% | +1.6 pp |
| FY2018 | 12.2% | +4.5 pp |
| FY2017 | 7.7% | +5.5 pp |
| FY2016 | 2.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More MEDP financial trends
MEDP RevenueMEDP Net incomeMEDP Net marginMEDP Gross profitMEDP Gross marginMEDP Operating incomeMEDP Operating marginMEDP Operating cash flowMEDP Free cash flowMEDP Capital expendituresMEDP Stock buybacksMEDP Dividends paidMEDP Total assetsMEDP Total liabilitiesMEDP Shareholders’ equityMEDP overview →